Welcome, visitor! [ Register | Login rss Google+ facebook twitter LinkedIn Pinterest

Sanford-Burnham and Daiichi Sankyo team up to develop treatment of cardiovascular-metabolic diseases

| Research and Development | 05/21/2014

Daiichi Sankyo and Sanford-Burnham Medical Research

Sanford-Burnham and Daiichi Sankyo Form Alliance to Study Novel Drug Targets in Cardiovascular-Metabolic Diseases
Date: May 21, 2014
Source: Daiichi Sankyo, Inc.

Orlando, Fla., U.S. and Tokyo, Japan(May 21, 2014) – Sanford-Burnham Medical Research Institute (Sanford-Burnham) and Daiichi Sankyo Co., Ltd. (Daiichi Sankyo) today announced they have entered into a three-year comprehensive alliance to develop first-in-class therapeutics for the treatment of cardiovascular-metabolic diseases.

Continue reading »

  • Japanese Companies - ""...

  • Japanese Companies - ""...

  • Japanese Companies - ""...

  • Japanese Companies - ""...

  • Japanese Companies - ""...

Group Sites

  • Ad 1
  • Ad 2
  • Ad 3
  • Ad 4